(Health-NewsWire.Net, August 04, 2016 ) Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell. They are complex proteins with high molecular weight, and were first developed in 1975 by Kohler and Milstein.
Technavios analysts forecast the global monoclonal antibodies (mAbs) market to grow at a CAGR of 9.84% during the period 2016-2020.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=768108
Covered in this report The report covers the present scenario and the growth prospects of the global monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded mAbs and biosimilars used to treat cancer, autoimmune and inflammatory diseases, respiratory diseases, and ophthalmology. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market, along with the decline in revenues from the patent expiries of the marketed drugs, during the forecast period.
The market is divided into the following segments based on geography: Americas APAC EMEA
New report, Global Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors AbbVie Amgen Bristol-Myers Squibb F. Hoffmann-La Roche Johnson & Johnson Merck
Browse Detail Report With TOC @ http://www.researchmoz.us/global-monoclonal-antibodies-market-2016-2020-report.html
Other prominent vendors AbGenomics ADC Therapeutics Agensys Alexion Pharmaceuticals ALMAC Group Ambrx Astellas Pharma AstraZeneca Bayer HealthCare Biogen Celgene Celldex Therapeutics Daiichi Sankyo Eisai Eli Lilly Formation Biologics Genmab GlaxoSmithKline Human Genome Sciences Immunogen MedImmune Novartis Pfizer Seattle Genetics Stemcentrx Synthon Biopharmaceuticals Takeda Pharmaceuticals Teva UCB
Market driver Special regulatory drug designations For a full, detailed list, view our report
Market challenge High manufacturing costs coupled with stringent regulations For a full, detailed list, view our report
Market trend Growing focus of vendors on untapped markets For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=768108
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|